Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
about
Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaAdvances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma"Weighing the risk": Obesity and outcomes following liver transplantationCardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective studyNAFLD and liver transplantation: Current burden and expected challenges.Endpoints and clinical trial design for nonalcoholic steatohepatitis.Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus InfectionData mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma.Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.Histopathology of nonalcoholic fatty liver disease.Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisNonalcoholic Fatty liver disease and obesity.Microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications.Non-alcoholic fatty liver disease: an overview.Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.Hepatic steatosis in obese patients: clinical aspects and prognostic significance.Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease.Should nonalcoholic fatty liver disease be renamed?Liver transplantation in adults: Choosing the appropriate timingCould post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?Cryptogenic cirrhosis and NAFLD: are they related?Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study.Medical Management of Metabolic Complications of Liver Transplant Recipients.Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.Recurrent nonviral liver disease following liver transplantation.Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.Pathophysiology of NASH: perspectives for a targeted treatment.Recurrence of non-viral liver disease after orthotopic liver transplantation.Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation.Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation.Natural History of Nonalcoholic Fatty Liver Disease.Clinicopathological features of non-alcoholic fatty liver disease.Nonalcoholic fatty liver disease following liver transplantation.Resting and Exercise Energy Metabolism After Liver Transplantation for Nonalcoholic Steatohepatitis.Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related.Prevalence and factors associated with dyslipidemia after liver transplantation.
P2860
Q26781477-7BE1ADB0-4907-42E2-8B79-68C228E3A395Q26795529-D5086E27-86D8-49D7-AD9F-55C41A57B929Q26859205-B2DD341F-948A-4414-8AD0-B8D9D3BD8B8DQ28074308-F2A121DB-DB54-454D-8776-A090BDA5F2BFQ30248646-7C491FAA-CD0A-4C07-AD08-8CEF81DEAAD9Q33583798-3E6FC414-9E97-44FE-BE1C-D20E074C1DF1Q33871776-BD2BC857-4C19-4E48-AC82-45DCD6AA7487Q33875631-5E732D3D-6D16-45FF-8C72-4F183E03F26BQ33891750-20EEAD97-0A1A-4EB0-AF52-D24E77ED6D57Q34306736-0FF26281-BC97-4A16-99C9-C0DF85DC32E8Q34499029-24A87CA6-37AB-48E2-B8D0-EE19EA11EBB6Q34605022-6240A581-4041-4476-B8CC-ADFE32741CAEQ34974769-BDA386DD-59E5-4A13-A24D-2FA84BE2E9E4Q35009628-075D9C4B-84AF-4A0D-95BA-B96D4ECA1028Q35012074-2279B8F1-14F0-48DB-9B9F-294A268A8C7CQ35538766-9CD4CAB3-3389-48CD-A627-DE488B449316Q35669794-59C6469E-9DBE-4E95-99D0-A97F78EDCBB3Q35868386-52375B31-711F-4D05-BB10-CE0825512A1AQ35984078-16F4477D-02E3-4118-844B-066CD23143BBQ36141458-AB93CAB3-6F44-49DB-886F-446E24C4391DQ36220176-6B1BCDE1-AC7B-4E20-8C5B-842F54885AA4Q36250837-9ED49659-A326-48C1-83A1-B62AE9123D6DQ36389812-7BE5B3CE-5E0F-4AD9-9ADE-79E154865D9DQ37154805-23C7E0E4-9331-4FEF-85E5-8AF089EE8A36Q37421526-FADCA3B6-5860-4C50-854F-E58A77F4DCEBQ37439861-CA67859D-3211-46E2-A129-6B1AC09DE6F8Q37503375-821F83CE-0E39-4E88-BADF-66EB6A52EB82Q37678998-7282BC47-D31F-4E7D-8643-B82378DAF260Q37699476-66DF7D71-EFED-4C4E-89CC-E461B592D2DDQ37833670-D064B196-B6AA-4611-9B20-D77C81404248Q37863136-42752E63-2AB6-409B-AB80-97C49AE39FBDQ38022211-9251AF11-E78F-476A-9928-2E610C7A3B4EQ38682089-41617C83-9CF6-414B-B10D-B6D4E16DB763Q38784787-37AC7E28-8F11-478E-910A-650B97231F14Q39703615-D3FBFFC4-5D40-4CCA-B24B-4BD5A44E4DA5Q40707333-EC881E1A-0B8C-4253-8B23-E25BCE0168DCQ41217227-2C132103-20C7-4EDE-A051-A417120C0D0AQ44348839-2EBF17AC-25E3-40A2-B38E-358ECE4EBE16Q44700468-A87EFC94-3466-4485-B7B7-85A62E9FE3A6Q45713421-53BE1111-E815-4D54-A902-840FADE6CF4E
P2860
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@ast
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@en
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@nl
type
label
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@ast
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@en
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@nl
prefLabel
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@ast
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@en
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@nl
P2093
P356
P1476
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
@en
P2093
Gramlich T
Younossi ZM
P304
P356
10.1053/JLTS.2001.24644
P577
2001-09-01T00:00:00Z